Related Experiment Video
Updated: Aug 16, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetic cardiomyopathy: Clinical phenotype and practice
Xudong Zhao1,2, Shengwang Liu3,2, Xiao Wang3,2
1Department of Endocrine and Metabolic Diseases, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Xiqing, Tianjin, China.
Insights
Diabetic cardiomyopathy (DCM) involves heart changes in diabetes patients, increasing heart failure risk. This review examines DCM
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetic cardiomyopathy (DCM) is a cardiac condition in diabetic individuals.
- It occurs independently of coronary artery disease and hypertension.
- DCM significantly elevates the risk of heart failure, yet effective treatments are limited.
Purpose of the Study:
- To review the literature on diabetic cardiomyopathy over the past 40 years.
- To provide an updated perspective on DCM's complex phenotype and progression.
- To explore potential clinical indicators, diagnostic criteria, and existing clinical trials for DCM.
Main Methods:
- Comprehensive literature search on diabetic cardiomyopathy.
- Analysis of studies published over the last four decades.
- Synthesis of findings regarding DCM's characteristics, progression, and management.
Main Results:
- The complex phenotype of DCM remains incompletely understood despite extensive research.
- Understanding DCM is crucial for advancing clinical and basic research.
- A comprehensive overview of DCM's progression, indicators, and trials is presented.
Conclusions:
- Diabetic cardiomyopathy presents a significant clinical challenge with poor prognosis.
- Further research is needed to fully elucidate DCM's mechanisms and improve patient outcomes.
- This review aims to consolidate current knowledge and guide future investigations into DCM.
Abstract:
Diabetic cardiomyopathy (DCM) is a pathophysiological condition of cardiac structure and function changes in diabetic patients without coronary artery disease, hypertension, and other types of heart diseases. DCM is not uncommon in people with diabetes, which increases the risk of heart failure. However, the treatment is scarce, and the prognosis is poor. Since 1972, one clinical study after another on DCM has been conducted. However, the complex phenotype of DCM still has not been fully revealed. This dilemma hinders the pace of understanding the essence of DCM and makes it difficult to carry out penetrating clinical or basic research. This review summarizes the literature on DCM over the last 40 years and discusses the overall perspective of DCM, phase of progression, potential clinical indicators, diagnostic and screening criteria, and related randomized controlled trials to understand DCM better.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management